Armistice Capital »

Kadant shares owned by Armistice Capital

Quarter-by-quarter ownership of Kadant (KAI) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Kadant

Tip: Access up to 7 years of quarterly data

All positions including Kadant held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kadant by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $216k 725 297.58

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Kadant

BlackRock
Vanguard Group
Kayne Anderson Rudnick Investment Management
Daniel D. Thurber
Capital Research and Management Company - Division 3
State Street Corporation
Neuberger Berman Group
Morgan Stanley
Capital World Investors
Geode Capital Management
Macquarie Group
Dimensional Fund Advisors
Champlain Investment Partners
Chevy Chase Trust Holdings
Riverbrige Partners

View all funds holding Kadant